US Broker Ratings

Alphatec Holdings, Inc. (ATEC) Stock Analysis: A 55% Potential Upside in the Medical Device Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC), a dynamic player in the healthcare sector, is making waves in the medical devices industry with its innovative approach to spinal..

Progyny, Inc. (PGNY) Investor Outlook: Analyzing a Promising 24.43% Potential Upside in Healthcare Plans

Progyny, Inc. (NASDAQ: PGNY) is making waves in the healthcare sector with its innovative approach to fertility and family-building benefits. As a benefits management company, Progyny..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating the Upside with Strategic Growth in Rare Disease Therapeutics

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is carving out a niche in the biotechnology sector with its focus on rare diseases, presenting unique opportunities for investors seeking..

Alvotech (ALVO) Stock Analysis: Exploring a 315.88% Upside Potential in the Biosimilar Market

Alvotech (ALVO), a Luxembourg-based healthcare company, is swiftly gaining traction in the biosimilar medicines sector. With an impressive market capitalization of $1.66 billion, Alvotech is positioning..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 54% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (NYSE: ARDT) is making waves in the healthcare sector, particularly among investors eyeing significant growth potential. With a market capitalization of $1.21 billion,..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Gem with 52% Upside Potential

For investors seeking opportunities in the dynamic world of biotechnology, NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS) presents a compelling case with a potential upside of 52.07%...

Warby Parker Inc. (WRBY) Stock Analysis: Exploring the Healthcare Innovator’s Growth Potential

Warby Parker Inc. (NYSE: WRBY), a renowned name in the eyewear industry, has positioned itself as a formidable player in the healthcare sector, specifically within the..

Harmony Biosciences Holdings (HRMY) Investor Outlook: A Promising 24.34% Upside Potential

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) stands as a compelling opportunity for investors in the biotechnology sector, with its current market dynamics suggesting a potential upside..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring a 163% Potential Upside Amidst Promising Rare Disease Treatments

Investors with a keen interest in the biotechnology sector might want to take a closer look at Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE). With a market capitalization..

Organon & Co. (OGN) Stock Analysis: Navigating a Challenging Landscape with Strategic Potential

Organon & Co. (OGN), a prominent player in the healthcare sector, primarily operates within the drug manufacturers-general industry. With a market capitalization of $2.37 billion, the..

Enovis Corporation (ENOV) Stock Analysis: Exploring a Healthcare Investment with 100% Upside Potential

Enovis Corporation (NYSE: ENOV) offers an intriguing opportunity for investors seeking exposure to the healthcare sector, specifically within the medical devices industry. With a market capitalization..

CG Oncology, Inc. (CGON) Stock Analysis: A Biotech Gem with 48.62% Upside Potential

In the fast-evolving world of biotechnology, CG Oncology, Inc. (NASDAQ: CGON) is capturing investor attention with its promising pipeline of bladder cancer therapeutics. With a robust..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Volatility with a 5.03% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY) stands as a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. With its headquarters in Charlotte,..

Mirum Pharmaceuticals, Inc. (MIRM): A Promising Biotech Play with a 12.88% Upside Potential

For investors keeping a close watch on the biotechnology sector, Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) presents a compelling opportunity. With a robust market capitalization of $5.01..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 45% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a key player in the biotechnology industry, holds a promising position in the healthcare sector with its focus on developing treatments..

Perrigo Company plc (PRGO): Investor Outlook Reveals a Potential 45.83% Upside

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector, is making waves with a potential upside of 45.83% as suggested by its average..

Zai Lab Limited (ZLAB) Stock Analysis: Eyeing a 169% Potential Upside in the Biotech Arena

Zai Lab Limited (NASDAQ: ZLAB) has emerged as a significant player in the biotech sector, with a focus on pioneering therapies in oncology, immunology, neuroscience, and..

Merus N.V. (MRUS) Stock Analysis: Exploring the Potential 7.78% Upside in the Biotech Sector

Merus N.V. (MRUS), a prominent player in the biotechnology sector, operates from the Netherlands with a keen focus on developing innovative antibody therapeutics. Although Merus is..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Healthcare Innovator with 29.67% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is generating buzz in the healthcare sector as a promising player in the health information services industry. Based in Arlington,..

Concentra Group Holdings Parent (CON) Stock Analysis: A Healthcare Play with a 28% Upside Potential

Investors with a keen eye on the healthcare sector may find Concentra Group Holdings Parent (NASDAQ: CON) an intriguing opportunity. With its robust presence in the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds